Clincosm LogoSign in Get a demo

advanced pancreatic cancer

Showing 26 - 41 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Pancreatic Cancer Trial in Beijing (Nab-paclitaxel and S-1)

Completed
  • Advanced Pancreatic Cancer
  • Nab-paclitaxel and S-1
  • Beijing, China
    National Cancer Center/Cancer Hospital, Chinese ACademy of Medic
Jan 29, 2021

Advanced Pancreatic Cancer Trial in Shanghai (cisplatin+Nab-paclitaxel+GEM, Nab-paclitaxel+GEM)

Not yet recruiting
  • Advanced Pancreatic Cancer
  • Shanghai, Sahnghai, China
    Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Jan 10, 2021

Advanced Pancreatic Cancer Trial in Guangzhou (Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Pancreatic Cancer,

Withdrawn
  • Advanced Pancreatic Cancer
  • Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Pancreatic Cancer
  • cryotherapy
  • Guangzhou, Guangdong, China
    Institutional Review Board of Guangzhou Fuda Cancer Hospital
Oct 13, 2020

Advanced Pancreatic Cancer Trial in New York (ADI-PEG 20)

Completed
  • Advanced Pancreatic Cancer
  • ADI-PEG 20
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Sep 30, 2020

Advanced Pancreatic Cancer Trial in Shanghai, Hangzhou (Fluzoparib, Fluzoparib , mFOLFIRINOX)

Recruiting
  • Advanced Pancreatic Cancer
  • Shanghai, Shanghai, China
  • +1 more
Aug 9, 2020

Advanced Pancreatic Cancer Trial in Honolulu (Gemcitabine, Nab-paclitaxel, ALT-803)

Completed
  • Advanced Pancreatic Cancer
  • Gemcitabine
  • +2 more
  • Honolulu, Hawaii
    University of Hawaii Cancer Center
Jan 24, 2020

Advanced Pancreatic Cancer Trial in Beijing (PEG-rhG-CSF)

Unknown status
  • Advanced Pancreatic Cancer
  • Beijing, China
    Chinese PLA General Hospital First medical center
Jan 20, 2020

Advanced Pancreatic Cancer Trial in Shanghai (Paclitaxel liposome, S-1)

Not yet recruiting
  • Advanced Pancreatic Cancer
  • Paclitaxel liposome
  • S-1
  • Shanghai, China
    Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Jan 1, 2020

Advanced Pancreatic Cancer Trial in United States (erlotinib, gemcitabine, nab-paclitaxel)

Completed
  • Advanced Pancreatic Cancer
  • Palm Springs, California
  • +4 more
Jun 5, 2019

Advanced Pancreatic Cancer Trial (Apatinib, S-1)

Unknown status
  • Advanced Pancreatic Cancer
  • (no location specified)
Sep 18, 2018

Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in United States (PRI-724)

Completed
  • Advanced Pancreatic Cancer
  • +2 more
  • Los Angeles, California
  • +4 more
Aug 16, 2017

Advanced Pancreatic Cancer Trial in Beijing (nanoparticle albumin-bound paclitaxel, S-1)

Unknown status
  • Advanced Pancreatic Cancer
  • nanoparticle albumin-bound paclitaxel
  • S-1
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 21, 2016

Advanced Pancreatic Cancer Trial in Spain (Nab-paclitaxel 150 mg/m2 + Gemcitabine 1000 weeks 1,3/4, Nab-paclitaxel 100 mg/m2 +

Completed
  • Advanced Pancreatic Cancer
  • Nab-paclitaxel 150 mg/m2 + Gemcitabine 1000 weeks 1,3/4
  • +3 more
  • Santiago de Compostela, A Cosuña, Spain
  • +14 more
Jul 5, 2016

Advanced Pancreatic Cancer Trial in Pittsburgh (Embedded Supportive Care)

Completed
  • Advanced Pancreatic Cancer
  • Embedded Supportive Care
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute (UPCI), Hillman Cancer
May 10, 2016

Advanced Pancreatic Cancer Trial in Beijing (nanoparticle albumin-bound paclitaxel, gemcitabine)

Unknown status
  • Advanced Pancreatic Cancer
  • Beijing, Beijing, China
    Chinese PLA General Hospital
May 15, 2014

Advanced Pancreatic Cancer Trial in Sutton (Gemcitabine, Oxaliplatin, Imatinib)

Completed
  • Advanced Pancreatic Cancer
  • Sutton, Surrey, United Kingdom
    Royal Marsden NHS Foundation Trust
Sep 21, 2012